Serves a dual role, tracking both production of reagents for RNA interference (RNAi) screening in Drosophila cells and RNAi screen results. FlyRNAi is used as a platform for community availability of protocols, tools, and other resources useful to researchers planning, conducting, analyzing or interpreting the results of Drosophila RNAi screens.
Department of Genetics, Harvard Medical School, Boston, MA, USA; Drosophila RNAi Screening Center and Transgenic RNAi Project, Harvard Medical School, Boston, MA, USA; Marine Science Center, Northeastern University, Nahant, MA, USA; Howard Hughes Medical Institute, Boston, MA, USA
FlyRNAi funding source(s)
This work was supported by NIH NIGMS [R01 GM067761, NIGMS R01 GM084947]; NIH [R24 RR032668, R24 OD021997]; Dana Farber/Harvard Cancer Center [NCI Cancer Center Support Grant # NIH 5 P30 CA06516]; Howard Hughes Medical Institute.